Seattle, WA, United States of America

Allen Turner



 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Allen Turner in Leukocyte Enrichment

Introduction

Allen Turner is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of biotherapeutics, particularly in the development of devices for leukocyte enrichment. With a total of two patents to his name, Turner is recognized for his innovative approaches to enhancing blood constituent separation.

Latest Patents

Turner's latest patents focus on tangential flow filtration devices and methods for leukocyte enrichment. The inventions provide a means to enrich a heterogeneous mixture of blood constituents for leukocytes by effectively removing non-leukocyte blood constituents. One embodiment of the device includes a remover unit featuring a crossflow chamber separated by a microporous filter from a filtrate chamber. This design allows for a tangential flow inlet, a fluid outlet for leukocyte-enriched fluid, and a filtrate outlet. The technology aims to provide a composition enriched in monocytes, which can be crucial for various medical applications.

Career Highlights

Allen Turner is currently associated with Northwest Biotherapeutics, Inc., where he continues to innovate in the field of biotherapeutics. His work has been instrumental in advancing methods that improve the efficiency of leukocyte separation, which is vital for research and therapeutic purposes.

Collaborations

Turner collaborates with notable colleagues, including Marnix L Bosch and Paul C Harris. Their combined expertise contributes to the ongoing development of innovative solutions in the biotherapeutics sector.

Conclusion

Allen Turner's contributions to the field of leukocyte enrichment through his patented inventions demonstrate his commitment to advancing medical technology. His work at Northwest Biotherapeutics, Inc. continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…